CTNM
Price
$5.77
Change
+$0.07 (+1.23%)
Updated
Jul 25 closing price
Capitalization
149.28M
23 days until earnings call
SLXN
Price
$0.86
Change
+$0.02 (+2.38%)
Updated
Jul 25 closing price
Capitalization
7.51M
Interact to see
Advertisement

CTNM vs SLXN

Header iconCTNM vs SLXN Comparison
Open Charts CTNM vs SLXNBanner chart's image
Contineum Therapeutics
Price$5.77
Change+$0.07 (+1.23%)
Volume$164.78K
Capitalization149.28M
Silexion Therapeutics
Price$0.86
Change+$0.02 (+2.38%)
Volume$157.88K
Capitalization7.51M
CTNM vs SLXN Comparison Chart in %
Loading...
CTNM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SLXN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CTNM vs. SLXN commentary
Jul 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CTNM is a Hold and SLXN is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 27, 2025
Stock price -- (CTNM: $5.77 vs. SLXN: $0.86)
Brand notoriety: CTNM and SLXN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CTNM: 68% vs. SLXN: 17%
Market capitalization -- CTNM: $149.28M vs. SLXN: $7.51M
CTNM [@Biotechnology] is valued at $149.28M. SLXN’s [@Biotechnology] market capitalization is $7.51M. The market cap for tickers in the [@Biotechnology] industry ranges from $313.33B to $0. The average market capitalization across the [@Biotechnology] industry is $2.57B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CTNM’s FA Score shows that 1 FA rating(s) are green whileSLXN’s FA Score has 0 green FA rating(s).

  • CTNM’s FA Score: 1 green, 4 red.
  • SLXN’s FA Score: 0 green, 5 red.
According to our system of comparison, CTNM is a better buy in the long-term than SLXN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CTNM’s TA Score shows that 6 TA indicator(s) are bullish while SLXN’s TA Score has 5 bullish TA indicator(s).

  • CTNM’s TA Score: 6 bullish, 4 bearish.
  • SLXN’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, CTNM is a better buy in the short-term than SLXN.

Price Growth

CTNM (@Biotechnology) experienced а +32.64% price change this week, while SLXN (@Biotechnology) price change was +4.31% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.60%. For the same industry, the average monthly price growth was +17.32%, and the average quarterly price growth was +27.29%.

Reported Earning Dates

CTNM is expected to report earnings on Aug 19, 2025.

Industries' Descriptions

@Biotechnology (+7.60% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CTNM($149M) has a higher market cap than SLXN($7.51M). SLXN YTD gains are higher at: -57.035 vs. CTNM (-60.614). SLXN has higher annual earnings (EBITDA): -16.96M vs. CTNM (-50.16M). CTNM has more cash in the bank: 191M vs. SLXN (6.15M). SLXN has less debt than CTNM: SLXN (3.48M) vs CTNM (6M). CTNM (0) and SLXN (0) have equivalent revenues.
CTNMSLXNCTNM / SLXN
Capitalization149M7.51M1,985%
EBITDA-50.16M-16.96M296%
Gain YTD-60.614-57.035106%
P/E Ratio26.40N/A-
Revenue00-
Total Cash191M6.15M3,105%
Total Debt6M3.48M172%
TECHNICAL ANALYSIS
Technical Analysis
CTNMSLXN
RSI
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
70%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
6%
Momentum
ODDS (%)
Bullish Trend 3 days ago
74%
Bullish Trend 3 days ago
25%
MACD
ODDS (%)
Bullish Trend 3 days ago
80%
Bullish Trend 3 days ago
29%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
76%
Bullish Trend 3 days ago
26%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
76%
Bullish Trend 3 days ago
29%
Advances
ODDS (%)
Bullish Trend 3 days ago
73%
Bullish Trend 5 days ago
51%
Declines
ODDS (%)
Bearish Trend 14 days ago
90%
Bearish Trend 7 days ago
75%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
27%
Aroon
ODDS (%)
Bullish Trend 3 days ago
64%
Bearish Trend 3 days ago
64%
View a ticker or compare two or three
Interact to see
Advertisement
CTNM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SLXN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
JFIL0.04N/A
N/A
Jubilant Flame International Ltd.
DAWIF10.20N/A
N/A
Daiwa Industires Ltd
LGGNY17.29-0.06
-0.35%
Legal & General Group Plc
SHCAY1.12-0.01
-0.45%
Sharp Corp.
MGMLF0.06N/A
-1.61%
Maple Gold Mines Ltd.

CTNM and

Correlation & Price change

A.I.dvisor tells us that CTNM and CCCC have been poorly correlated (+33% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CTNM and CCCC's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CTNM
1D Price
Change %
CTNM100%
+1.23%
CCCC - CTNM
33%
Poorly correlated
-1.31%
RGNX - CTNM
32%
Poorly correlated
-1.86%
ARMP - CTNM
31%
Poorly correlated
-3.82%
XNCR - CTNM
31%
Poorly correlated
N/A
VYGR - CTNM
30%
Poorly correlated
-2.11%
More

SLXN and

Correlation & Price change

A.I.dvisor tells us that SLXN and CHRS have been poorly correlated (+24% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that SLXN and CHRS's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SLXN
1D Price
Change %
SLXN100%
-2.01%
CHRS - SLXN
24%
Poorly correlated
+1.96%
FBRX - SLXN
23%
Poorly correlated
+7.91%
ORIC - SLXN
20%
Poorly correlated
-2.47%
CTNM - SLXN
9%
Poorly correlated
+1.23%
KLTO - SLXN
7%
Poorly correlated
-3.15%
More